Evidence map›Paper›PMID 35181860›Full record

ArticleEcotoxicology (London, England)2022

Response of hepatic biomarkers in Physalaemus nattereri (Anura) to different benzo(α)pyrene exposure routes.

Bruno Serra de Lacerda Valverde, Heidi Samantha Moraes Utsunomiya, Cleoni Dos Santos Carvalho, Lilian Franco-Belussi, Classius de Oliveira

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Ecotoxicology (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Bruno Serra de Lacerda ValverdeGraduate Program in Biodiversity, Department of Biology, São Paulo State University (UNESP), Cristóvão Colombo 2265, 15054-000, São José do Rio Preto, São Paulo, Brazil. bruno-valverde@hotmail.com.ORCID http://orcid.org/0000-0001-9039-9817
Heidi Samantha Moraes UtsunomiyaUniversidade Federal de São Carlos, campus Sorocaba, Laboratório de Bioquímica e Microbiologia (LaBioM), Rodovia João Leme dos Santos, Km 11, SP-264, 18052-780, Sorocaba, São Paulo, Brazil.
Cleoni Dos Santos CarvalhoUniversidade Federal de São Carlos, campus Sorocaba, Laboratório de Bioquímica e Microbiologia (LaBioM), Rodovia João Leme dos Santos, Km 11, SP-264, 18052-780, Sorocaba, São Paulo, Brazil.ORCID http://orcid.org/0000-0003-0755-5239
Lilian Franco-BelussiInstitute of Biosciences, Universidade Federal de Mato Grosso do Sul (UFMS), Cidade Universitária 79070-900, Campo Grande, Mato Grosso do Sul, Brazil.ORCID http://orcid.org/0000-0003-1938-8423
Classius de OliveiraDepartment of Biology, São Paulo State University (UNESP), Cristóvão Colombo 2265, 15054-000, São José do Rio Preto, São Paulo, Brazil.ORCID http://orcid.org/0000-0002-2029-7900
Universidade Federal de São Carlos · BRCentro Universitário de Rio Preto · BRUniversidade Estadual Paulista (Unesp) · BRUniversidade Federal de Mato Grosso do Sul · BR

Funding

conselho nacional de desenvolvimento científico e tecnológico 304552/2019-4fundação de amparo à pesquisa do estado de são paulo 2018/01078-7
6 · The paper itself

Abstract

For over 40 years, anurans have been used as a study model to assess the adverse effects of benzo(α)pyrene (BαP), which include genotoxic, hepatotoxic, and immunotoxic effects. In these studies, BαP is administered cutaneously or by injection, with no comparison between two or more routes. The purpose of this study is to assess whether the effect of BαP is influenced by its route of administration, using the response of hepatic biomarkers of Physalaemus nattereri. Specimens (n = 108) were collected and divided into three experimental treatments (cutaneous, injection, and oral) and three experimental times (one, three, and seven days). Specimens received 0.02 ml of pure mineral oil (control) or mineral oil containing 2 mg/kg of BαP. The BαP causes changes in morphological (melanin, hemosiderin, lipofuscin, and mast cells) and biochemical (superoxide dismutase and glutathione S-transferase) hepatic biomarkers. Compared to biochemical, morphological biomarkers underwent a greater number of significant changes due to the treatment with BαP. The route of exposure alters the effects of BαP, mainly seen in morphological biomarkers, especially the pigments melanin, hemosiderin, and lipofuscin. In these pigments, the effect of the exposure pathway changes according to the analyzed biomarker, and the exposure time modulates the exposure pathway effect. These results are unprecedented for anurans and contribute to the field of herpetology and ecotoxicology.

Indexed as

AnuraBenzo(a)pyreneAnimalsBiomarkersEcotoxicologyLiverBenzo(a)pyreneBiomarkersGlutathione S-transferaseLiverMelanomacrophagePolycyclic aromatic hydrocarbonsSuperoxide dismutase

Identifiers

PMID35181860
OpenAlexW4213240555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.